Polaryx Therapeutics Inc (PLYX)

Apr 02, 2026

Polaryx Therapeutics, Inc. (PLYX) stock price, news, quote and history - Yahoo Finance UK

Apr 02, 2026

Apr 02, 2026

PLYX: Polaryx Therapeutics, Inc.Options Chain - Zacks Investment Research

Apr 02, 2026

Apr 01, 2026

Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference - Bitget

Apr 01, 2026

Apr 01, 2026

Polaryx to webcast Needham healthcare presentation on Apr. 16 - stocktitan.net

Apr 01, 2026

Mar 28, 2026

Polaryx Therapeutics Inc (NASDAQ: PLYX)Share Price - intelligentinvestor.com.au

Mar 28, 2026

Mar 27, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 27, 2026

Mar 25, 2026

Harmony Biosciences stock faces pipeline scrutiny amid Polaryx integration challenges and rare disea - AD HOC NEWS

Mar 25, 2026

Mar 24, 2026

Polaryx Therapeutics: Advancing Innovative Therapies for Rare Pediatric Lysosomal Storage Disorders (LSDs) - Minichart

Mar 24, 2026

Mar 24, 2026

Polaryx Therapeutics (NASDAQ: PLYX) outlines rare pediatric LSD pipeline - Stock Titan

Mar 24, 2026

Mar 24, 2026

PLYX: Net loss improved to $9.0M in 2025, but cash only funds operations through Q3 2026 - TradingView

Mar 24, 2026

Mar 23, 2026

Polaryx Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Mar 23, 2026

Mar 22, 2026

Polaryx Therapeutics, Inc.(NasdaqCM: PLYX) added to S&P TMI Index - marketscreener.com

Mar 22, 2026

Mar 19, 2026

Polaryx Therapeutics (PLYX) Stock Trends and Sentiment 2026 - MarketBeat

Mar 19, 2026

Mar 18, 2026

FDA grants fast track status to Polaryx’s PLX-200 for CLN2 disease By Investing.com - Investing.com South Africa

Mar 18, 2026

Mar 17, 2026

Polaryx Therapeutics (PLYX) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

Mar 17, 2026

Mar 17, 2026

Polaryx’s PLX-200 granted FDA Fast Track Designation in LINCL/CLN2 - tipranks.com

Mar 17, 2026

Mar 17, 2026

FDA grants fast track status to Polaryx’s PLX-200 for CLN2 disease - Investing.com

Mar 17, 2026

Mar 17, 2026

Polaryx Therapeutics Says FDA Grants Fast Track Status to PLX-200 - marketscreener.com

Mar 17, 2026

Mar 17, 2026

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease) - The Manila Times

Mar 17, 2026

Mar 17, 2026

FDA Fast Track for PLX‑200 targeting rare pediatric disorder - Stock Titan

Mar 17, 2026

Mar 17, 2026

Should I buy Polaryx Therapeutics, Inc. (PLYX) - Zacks Investment Research

Mar 17, 2026

Mar 16, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 16, 2026

Mar 15, 2026

Polaryx Therapeutics Stock Rises Amidst Key Clinical Trials Development - timothysykes.com

Mar 15, 2026

Mar 15, 2026

symbol__ Stock Quote Price and Forecast - CNN

Mar 15, 2026

Mar 14, 2026

Top Polaryx Therapeutics (PLYX) Competitors 2026 - MarketBeat

Mar 14, 2026

Mar 14, 2026

Polaryx Therapeutics Stock Surges With New Phase Trial Decision​ - StocksToTrade

Mar 14, 2026

Mar 12, 2026

PLYX Stock Rockets To Best Day Ever: Why Retail Traders Are Piling Into This Battered Biotech - Stocktwits

Mar 12, 2026

Mar 12, 2026

Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events - Bitget

Mar 12, 2026

Mar 12, 2026

Biotech backs Krabbe families with research summit and Putt-Putt event - Stock Titan

Mar 12, 2026

Mar 11, 2026

Battered Polaryx Stock Turns Retail-Trader Heads After 70% Surge: What’s Behind The Sudden Interest? - Asianet Newsable

Mar 11, 2026

Mar 11, 2026

Polaryx Therapeutics, Inc.Common Stock (Nasdaq:PLYX) Stock Quote - The Chronicle-Journal

Mar 11, 2026

Mar 10, 2026

Polaryx Therapeutics (PLYX) Insider Trading Activity 2026 - MarketBeat

Mar 10, 2026

Mar 06, 2026

PLYX Forecast, Price Target & Analyst Ratings | POLARYX THERAPEUTICS INC (NASDAQ:PLYX) - ChartMill

Mar 06, 2026

Mar 01, 2026

Polaryx Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | PLYX | US73110F1003 - marketscreener.com

Mar 01, 2026

Feb 27, 2026

Polaryx commits to patients with rare pediatric lysosomal storage disorders - TipRanks

Feb 27, 2026

Feb 27, 2026

Polaryx Therapeutics Inc (PLYX) Stock Price, Quote, News & History - Benzinga

Feb 27, 2026

Feb 27, 2026

Maxim starts Polaryx at Buy, sees PLX-200 as differentiated - TipRanks

Feb 27, 2026

Feb 27, 2026

PLYX | Polaryx Therapeutics, Inc. Common Analyst Forecasts - Quiver Quantitative

Feb 27, 2026

Feb 27, 2026

Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders - Bitget

Feb 27, 2026

Feb 27, 2026

PLYX | Polaryx Therapeutics, Inc. Common Insider Trading - Quiver Quantitative

Feb 27, 2026

Feb 27, 2026

Inside the rare childhood brain diseases Polaryx aims to tackle - Stock Titan

Feb 27, 2026

Feb 23, 2026

Mstone Partners Healthcare Highlights Polaryx Therapeutics’ Latest Preclinical Data Shared at WORLDSymposium™ - EIN News

Feb 23, 2026

Feb 21, 2026

Polaryx Therapeutics (PLYX) 10K Form and SEC Filings 2026 - MarketBeat

Feb 21, 2026

Feb 21, 2026

Polaryx Therapeutics (PLYX) Stock Forecast and Price Target 2026 - MarketBeat

Feb 21, 2026

Feb 20, 2026

Polaryx Therapeutics (PLYX) Stock Price, News & Analysis - MarketBeat

Feb 20, 2026

Feb 20, 2026

Polaryx Therapeutics (PLYX) Stock Chart and Price History 2026 - MarketBeat

Feb 20, 2026

Feb 20, 2026

Insider Buying: G. Landis Acquires Shares of Polaryx Therapeutics Inc (PLYX) - GuruFocus

Feb 20, 2026

Feb 19, 2026

PLYX Stock Price, News & Analysis - Stock Titan

Feb 19, 2026

Feb 18, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Feb 18, 2026